| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 22.40▲ | 22.36▲ | 22.36▲ | 22.54▲ | 22.00▲ |
| MA10 | 22.41▲ | 22.57▲ | 22.57▲ | 22.16▲ | 22.89▼ |
| MA20 | 23.21▼ | 23.35▼ | 23.35▼ | 21.99▲ | 23.71▼ |
| MA50 | 24.24▼ | 24.19▼ | N/A | 23.10▼ | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.026▼ | -0.072▼ | -0.080▼ | 0.177▲ | N/A |
| RSI | 41.898▼ | 41.785▼ | 42.350▼ | 53.183▲ | 44.554▼ |
| STOCH | 45.081 | 37.937 | 37.937 | 95.743▲ | 28.098 |
| WILL %R | -44.178 | -44.178 | -44.178 | -7.511▲ | -54.438 |
| CCI | -6.020 | -13.899 | -13.899 | 135.955▲ | -57.017 |
| ▲ BREAK | $PRVS Price Breaks 10 Days High | Set Alert |
|
Wednesday, April 30, 2025 07:05 AM
(NASDAQ:ABEO) announced that the U.S. Food and Drug Administration (FDA) has approved Zevaskyn (prademagene zamikeracel) for the treatment of wounds in adults and children with recessive dystrophic ...
|
|
Tuesday, April 29, 2025 09:29 PM
2-Year U.S. Treasury Note Continuous Contract $104.000-0.004 0.00% 5-Year U.S. Treasury Note Continuous Contract $109.109 0.016 0.01% 10-Year U.S. Treasury Note Continuous Contract $112.234 0.078 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 22.84 | 22.88 | 22.7433 | 22.7433 | 6,403 |
| 30/04/25 | 22.38 | 22.66 | 22.16 | 22.655 | 3,900 |
| 29/04/25 | 22.34 | 22.56 | 22.34 | 22.56 | 0 |
| 28/04/25 | 22.45 | 22.45 | 22.29 | 22.3944 | 753 |
| 25/04/25 | 22.29 | 22.3378 | 22.22 | 22.3378 | 1,335 |
| 24/04/25 | 22.23 | 22.3715 | 22.23 | 22.3715 | 701 |
| 23/04/25 | 22.42 | 22.45 | 22.035 | 22.035 | 2,800 |
| 22/04/25 | 21.55 | 21.73 | 21.54 | 21.689 | 3,100 |
| 21/04/25 | 21.50 | 21.50 | 21.06 | 21.202 | 10,500 |
| 17/04/25 | 21.72 | 21.72 | 21.64 | 21.64 | 400 |
|
|
||||
|
|
||||
|
|